Public health implications of sickle cell trait: A report of the CDC meeting

Althea M. Grant, Christopher S. Parker, Lanetta B Jordan, Mary M. Hulihan, Melissa S. Creary, Michele A. Lloyd-Puryear, Jonathan C. Goldsmith, Hani K. Atrash

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Although the issue of whether sickle cell trait (SCT) is clinically benign or a significant health concern has not yet been resolved, the potential health risk to affected individuals is of vital importance and represents a tremendous challenge in protecting, promoting, and improving the health of the approximately 300 million people worldwide and 3 million people in the U.S. who possess the trait. In response to a request by the Sickle Cell Disease Association of America, in December 2009, the CDC convened a meeting of partners, stakeholders, and experts to identify the gaps in public health, clinical health services, epidemiologic research, and community-based outreach strategies and to develop an agenda for future initiatives. Through facilitated discussion and presentations in four topic areas, participants discussed pertinent issues, synthesized clinical research findings, and developed a coherent framework for establishing an agenda for future initiatives. A primary outcome of the meeting was to provide the first step of an iterative process to move toward agreement regarding appropriate counseling, care, and, potentially, treatment of people with SCT.

Original languageEnglish
JournalAmerican Journal of Preventive Medicine
Volume41
Issue number6 SUPPL.4
DOIs
StatePublished - Dec 1 2011
Externally publishedYes

Fingerprint

Sickle Cell Trait
Centers for Disease Control and Prevention (U.S.)
Public Health
Health
Community-Institutional Relations
Health Services Research
Sickle Cell Anemia
Counseling
Research

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Grant, A. M., Parker, C. S., Jordan, L. B., Hulihan, M. M., Creary, M. S., Lloyd-Puryear, M. A., ... Atrash, H. K. (2011). Public health implications of sickle cell trait: A report of the CDC meeting. American Journal of Preventive Medicine, 41(6 SUPPL.4). https://doi.org/10.1016/j.amepre.2011.09.012

Public health implications of sickle cell trait : A report of the CDC meeting. / Grant, Althea M.; Parker, Christopher S.; Jordan, Lanetta B; Hulihan, Mary M.; Creary, Melissa S.; Lloyd-Puryear, Michele A.; Goldsmith, Jonathan C.; Atrash, Hani K.

In: American Journal of Preventive Medicine, Vol. 41, No. 6 SUPPL.4, 01.12.2011.

Research output: Contribution to journalArticle

Grant, AM, Parker, CS, Jordan, LB, Hulihan, MM, Creary, MS, Lloyd-Puryear, MA, Goldsmith, JC & Atrash, HK 2011, 'Public health implications of sickle cell trait: A report of the CDC meeting', American Journal of Preventive Medicine, vol. 41, no. 6 SUPPL.4. https://doi.org/10.1016/j.amepre.2011.09.012
Grant AM, Parker CS, Jordan LB, Hulihan MM, Creary MS, Lloyd-Puryear MA et al. Public health implications of sickle cell trait: A report of the CDC meeting. American Journal of Preventive Medicine. 2011 Dec 1;41(6 SUPPL.4). https://doi.org/10.1016/j.amepre.2011.09.012
Grant, Althea M. ; Parker, Christopher S. ; Jordan, Lanetta B ; Hulihan, Mary M. ; Creary, Melissa S. ; Lloyd-Puryear, Michele A. ; Goldsmith, Jonathan C. ; Atrash, Hani K. / Public health implications of sickle cell trait : A report of the CDC meeting. In: American Journal of Preventive Medicine. 2011 ; Vol. 41, No. 6 SUPPL.4.
@article{25f4becaba8649edbd4c81c86b7934b5,
title = "Public health implications of sickle cell trait: A report of the CDC meeting",
abstract = "Although the issue of whether sickle cell trait (SCT) is clinically benign or a significant health concern has not yet been resolved, the potential health risk to affected individuals is of vital importance and represents a tremendous challenge in protecting, promoting, and improving the health of the approximately 300 million people worldwide and 3 million people in the U.S. who possess the trait. In response to a request by the Sickle Cell Disease Association of America, in December 2009, the CDC convened a meeting of partners, stakeholders, and experts to identify the gaps in public health, clinical health services, epidemiologic research, and community-based outreach strategies and to develop an agenda for future initiatives. Through facilitated discussion and presentations in four topic areas, participants discussed pertinent issues, synthesized clinical research findings, and developed a coherent framework for establishing an agenda for future initiatives. A primary outcome of the meeting was to provide the first step of an iterative process to move toward agreement regarding appropriate counseling, care, and, potentially, treatment of people with SCT.",
author = "Grant, {Althea M.} and Parker, {Christopher S.} and Jordan, {Lanetta B} and Hulihan, {Mary M.} and Creary, {Melissa S.} and Lloyd-Puryear, {Michele A.} and Goldsmith, {Jonathan C.} and Atrash, {Hani K.}",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/j.amepre.2011.09.012",
language = "English",
volume = "41",
journal = "American Journal of Preventive Medicine",
issn = "0749-3797",
publisher = "Elsevier Inc.",
number = "6 SUPPL.4",

}

TY - JOUR

T1 - Public health implications of sickle cell trait

T2 - A report of the CDC meeting

AU - Grant, Althea M.

AU - Parker, Christopher S.

AU - Jordan, Lanetta B

AU - Hulihan, Mary M.

AU - Creary, Melissa S.

AU - Lloyd-Puryear, Michele A.

AU - Goldsmith, Jonathan C.

AU - Atrash, Hani K.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Although the issue of whether sickle cell trait (SCT) is clinically benign or a significant health concern has not yet been resolved, the potential health risk to affected individuals is of vital importance and represents a tremendous challenge in protecting, promoting, and improving the health of the approximately 300 million people worldwide and 3 million people in the U.S. who possess the trait. In response to a request by the Sickle Cell Disease Association of America, in December 2009, the CDC convened a meeting of partners, stakeholders, and experts to identify the gaps in public health, clinical health services, epidemiologic research, and community-based outreach strategies and to develop an agenda for future initiatives. Through facilitated discussion and presentations in four topic areas, participants discussed pertinent issues, synthesized clinical research findings, and developed a coherent framework for establishing an agenda for future initiatives. A primary outcome of the meeting was to provide the first step of an iterative process to move toward agreement regarding appropriate counseling, care, and, potentially, treatment of people with SCT.

AB - Although the issue of whether sickle cell trait (SCT) is clinically benign or a significant health concern has not yet been resolved, the potential health risk to affected individuals is of vital importance and represents a tremendous challenge in protecting, promoting, and improving the health of the approximately 300 million people worldwide and 3 million people in the U.S. who possess the trait. In response to a request by the Sickle Cell Disease Association of America, in December 2009, the CDC convened a meeting of partners, stakeholders, and experts to identify the gaps in public health, clinical health services, epidemiologic research, and community-based outreach strategies and to develop an agenda for future initiatives. Through facilitated discussion and presentations in four topic areas, participants discussed pertinent issues, synthesized clinical research findings, and developed a coherent framework for establishing an agenda for future initiatives. A primary outcome of the meeting was to provide the first step of an iterative process to move toward agreement regarding appropriate counseling, care, and, potentially, treatment of people with SCT.

UR - http://www.scopus.com/inward/record.url?scp=81355150248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81355150248&partnerID=8YFLogxK

U2 - 10.1016/j.amepre.2011.09.012

DO - 10.1016/j.amepre.2011.09.012

M3 - Article

C2 - 22099370

AN - SCOPUS:81355150248

VL - 41

JO - American Journal of Preventive Medicine

JF - American Journal of Preventive Medicine

SN - 0749-3797

IS - 6 SUPPL.4

ER -